|
Showing 1 - 2 of
2 matches in All Departments
|
Gain-of-Function Research - Summary of the Second Symposium, March 10-11, 2016 (Paperback)
National Academies of Sciences, Engineering, and Medicine, Policy and Global Affairs, Committee on Science, Technology, and Law, Health and Medicine Division, Board on Health Sciences Policy, …
|
R1,545
Discovery Miles 15 450
|
Ships in 12 - 17 working days
|
On March 10-11, 2016, the National Academies of Sciences,
Engineering, and Medicine held a public symposium on potential U.S.
government policies for the oversight of gain-of- function (GOF)
research. This was the Academies' second meeting held at the
request of the U.S. government to provide a mechanism to engage the
life sciences community and the broader public and solicit feedback
on optimal approaches to ensure effective federal oversight of GOF
research as part of a broader U.S. government deliberative process.
The first symposium, held in December 2014, examined the underlying
scientific and technical questions surrounding the potential risks
and benefits of GOF research involving pathogens with pandemic
potential. The second symposium focused on discussion of the draft
recommendations regarding GOF research of a Working Group of the
National Science Advisory Board for Biosecurity. This report
summarizes the key issues and ideas identified during the second
symposium. Table of Contents Front Matter 1 Introduction 2 The
Draft National Science Advisory Board for Biosecurity Policy
Framework, the Risk and Benefit Assessment, and Insights for the
Policy Process 3 Issues for U.S. Policy 4 International Policy 5
Summing Up Bibliography Appendix A: Board and Committee Members of
Collaborating Units Appendix B: Committee Biographies Appendix C:
Symposium Agenda Appendix D: Speaker and Panelist Biographies
Appendix E: List of Attendees
On October 17, 2014, spurred by incidents at U.S. government
laboratories that raised serious biosafety concerns, the United
States government launched a one-year deliberative process to
address the continuing controversy surrounding so-called
"gain-of-function" (GOF) research on respiratory pathogens with
pandemic potential. The gain of function controversy began in late
2011 with the question of whether to publish the results of two
experiments involving H5N1 avian influenza and continued to focus
on certain research with highly pathogenic avian influenza over the
next three years. The heart of the U.S. process is an evaluation of
the potential risks and benefits of certain types of GOF
experiments with influenza, SARS, and MERS viruses that would
inform the development and adoption of a new U.S. Government policy
governing the funding and conduct of GOF research. Potential Risks
and Benefits of Gain-of-Function Research is the summary of a
two-day public symposia on GOF research. Convened in December 2014
by the Institute of Medicine and the National Research Council, the
main focus of this event was to discuss principles important for,
and key considerations in, the design of risk and benefit
assessments of GOF research. Participants examined the underlying
scientific and technical questions that are the source of current
discussion and debate over GOF research involving pathogens with
pandemic potential. This report is a record of the presentations
and discussion of the meeting. Table of Contents Front Matter 1
Introduction 2 Assessing Risks and Benefits 3 Gain-of-Function
Research: Background and Alternatives 4 Potential Benefits of
Gain-of-Function Research 5 Potential Risks: Biosafety and
Biosecurity 6 Policy Implications References Appendix A: Key Issues
for Risk/Benefit Assessment for Gain-of-Function Research Appendix
B: Committee Biographies Appendix C: Agenda Appendix D: Speaker
Biographies Appendix E: List of Attendees Appendix F: Acronym List
|
|